The cardiovascular and renal benefits, combined with their impact on glucose levels and weight loss, make GLP-1-RAs a versatile therapeutic option for patients with T2DM, particularly for those at an increased risk of cardiovascular problems [16,66]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.